Carrascosa, R <br/><br/>
Does boceprevir really increase the risk of skin eruptions during antihepatitis C treatment?  [electronic resource] 

 -  The British journal of dermatology  Feb 2016 
 - 460-1 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1365-2133 
<br/><br/><label>Standard No.: </label>10.1111/bjd.14169  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--adverse effects<br/>Drug Eruptions--etiology<br/>Female<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Male<br/>Oligopeptides--adverse effects<br/>Proline--analogs & derivatives<br/>Protease Inhibitors--adverse effects